Connect Biopharma Holdings Ltd - ADR
CNTB
Get informed when a big investor buys or sells
+ FollowMarket Cap$125.93M
Close$
$0.68
67.6% downside
Current Fair Value
67.6% downsideOvervalued by 67.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $125.93 Million |
|---|---|
| Enterprise Value | $88.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | -0.21 |
| Outstanding Shares | 55,660,000 |
Return
| Return on Equity | -169.24% |
|---|---|
| Return on Assets | -126.70% |
| Return on Invested Capital | -185.13% |
Valuation & Multiples
| P/E Ratio | -4 |
|---|---|
| PEG | -4.8 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.39 |
| Enterprise Value to EBIT | -1.12 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$5,865
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4041▲ 40.41% |
|---|---|
| Total Calls | 196,500▲ 8.20% |
| Total Puts | 79,400▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 22.90%▲ 7.65% |
|---|---|
| Total Invested | $32.37M▲ 35.57% |
| Investors Holding | 46▲ 15.00% |
ESG Score
No data
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from its T cell-d...